Peptidomimetics
- Name
- Peptidomimetics
- Accession Number
- DBCAT003083
- Description
Not Available
- Drugs
Drug Drug Description LTX-109 LTX-109 has been investigated for the treatment of Atopic Dermatitis, Mild Eczema/Dermatoses, and Gram-positive, Skin Infections. - Drugs & Drug Targets
Drug Target Type